
CI AI Price Prediction
Track CI's AI-powered predictions, market trends, and investment insights.
You don't hold CI in your mock portfolio yet.
Track CI's AI-powered predictions, market trends, and investment insights.
You don't hold CI in your mock portfolio yet.
Upgrade to see the full Evidence Stack
What Changed, Why Now, and Risk Flags — available on the Investor plan and above
Get StartedCigna’s valuation and earnings metrics suggest very strong underlying profitability relative to its current share price. A PE ratio of 2.52 against an EPS of 113.72 implies the market is heavily discounting earnings, which can indicate either unusually high one‑time earnings or an undervalued stock. In either case, the earnings power implied by the EPS figure is a positive signal for the equity story.
Cigna’s stock is trading modestly above its 200‑day moving average and has gained 1.3% over the last month, indicating a mild upward bias but not a strong momentum breakout. The proximity to the 200‑day average suggests the stock is in a consolidation zone where neither bulls nor bears are clearly in control. Without RSI data, the technical picture looks balanced with a slight positive tilt.
Alternative data for Cigna show mixed but slightly negative demand and activity signals. While overall web traffic is high and LinkedIn followers are growing modestly, app downloads and job postings are both down meaningfully month over month, which can indicate softer near‑term growth or a more cautious operating stance. Social media followership is largely flat to slightly down across consumer‑facing platforms, pointing to limited incremental brand engagement momentum.
Cigna’s fundamentals and valuation lean bullish, but the technical picture and alternative data are more subdued, resulting in an overall neutral stance. Strong earnings relative to price suggest potential undervaluation, yet modest price momentum and softening alternative data (downloads, hiring, and flat social engagement) temper the outlook. Taken together, the setup looks more like a value story awaiting a clearer catalyst than a strongly directional opportunity in the near term.
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals.
Cigna (CI) posted a notable single-session gain of +3.7%, pushing its share price to $280.68 on volume of approximately 1.61 million shares. The move is attention-grabbing against the backdrop of a $74.2 billion market cap, suggesting meaningful institutional participation in the session. Cigna operates across two core segments — Evernorth, its health services and pharmacy benefits arm, and Cigna Healthcare, which covers medical, dental, behavioral health, and Medicare products. The day's momentum reflects short-term trader interest, though the broader trend picture requires closer scrutiny before drawing directional conclusions.
TrendEdge's AI model currently assigns Cigna a score of 4 out of 10, placing it in cautious territory. A score at this level typically reflects a combination of mixed momentum signals, limited near-term catalysts, and data inputs that do not yet support a high-conviction bullish thesis. While the single-day price pop is notable, the AI score weighs multiple factors beyond intraday moves — including trend consistency and alternative data signals. With only 22 active job postings, organic growth expansion appears measured rather than aggressive, which may be tempering the model's outlook for the near term.
One standout signal in Cigna's alternative data is a reported +90,000% surge in app downloads — an extraordinary figure that warrants monitoring for sustainability and whether it translates into member engagement or revenue impact. Investors should watch for quarterly earnings commentary on Evernorth's pharmacy benefits margins and Medicare Advantage enrollment trends, both of which are key pressure points for managed care valuations in 2026. Regulatory scrutiny on PBM pricing and healthcare cost inflation remain the primary macro risks for CI shareholders.
Unlock comprehensive alternative data signals to make better investment decisions
TrendEdge provides tools and data for research and educational purposes only and does not provide investment advice or personal recommendations.
Web Traffic
9,589,036
Twitter Followers
51,137
Instagram Followers
33,795
YouTube Subscribers
31,700
LinkedIn Followers
854,441
Job Postings
24
LinkedIn Employees
29,586
News Mentions
0
Key Metrics